Refine by
Biomarker Articles & Analysis
460 news found
They can be used as an exosome standard in the evaluation of biomarkers. CD Bioparticles is proud to provide a comprehensive range of high-purity exosomes, ensuring researchers have access to the highest quality materials for their critical work. ...
This link supports ongoing research into how metabolic changes influence brain function, and highlights ghrelin as a promising biomarker in psychiatric studies. Supporting depression and metabolism research To achieve accurate, reproducible results, the researchers used the Bertin Bioreagent Acylated Ghrelin (Human) Easy Sampling ELISA Kit. ...
In drug development, it is used to verify the N-terminal sequences of therapeutic proteins, ensuring proper folding and functionality. In biomarker discovery, it helps characterize N-terminal modifications that may serve as disease markers. ...
” She emphasized that understanding these metabolic processes not only aids in identifying biomarkers for diseases but also helps in the development of targeted therapies and optimization of bioproduction processes. ...
In addition to depression behavior testing services, Ace Therapeutics also provides drug safety and efficacy studies, new antidepressant development, biomarker-based diagnostic development, and brain imaging diagnostic development, all to facilitate the research on depression, deepen understanding, and ultimately contribute to more effective treatments and ...
Additionally, they are compatible with advanced imaging techniques and biomarker analyses, allowing researchers to gather comprehensive data on physiological responses and disease progression. ...
By leveraging its expertise in assay development, biomarker identification, and regulatory compliance, Protheragen aims to advance rare disease diagnostics and accelerate the path from diagnostic research to commercialization. ...
Chronic Obstructive Pulmonary Disease (COPD) is a global health burden characterized by persistent airflow limitation and progressive lung damage. Despite extensive research, translating findings from bench to bedside remains a challenge. Precision Cut Lung Slices (PCLS) have emerged as a versatile tool in COPD research, offering unique advantages for understanding disease mechanisms and ...
Building on our previous promising results in detecting CTCs in EBC, this study aims to further explore these biomarkers' potential in monitoring disease progression and guiding treatment ...
In this piece, we talked to the two presenters of the poster “The Validation of a Homologous Recombination Deficiency Assay into Clinical Practice within the NHS”, Elizabeth Ratsma, Pre-Registration Clinical Scientist – Cancer Genomics and Charlotte Flanagan, PhD, Innovation Lead, from The Royal Marsden NHS Foundation Trust. The poster was recently presented at the ESMO ...
By leveraging its expertise and resources, the company can develop animal models, cell models, multicellular models, pharmacokinetic/pharmacodynamic modeling, biomarker discovery, and more. These model development services are designed to offer researchers the tools and resources they need to optimize drug development and maximize success rates. ...
” More information about this collaboration will be provided during the World Clinical Biomarkers & CDx event in Boston on September 5, 2024. Learn more about the event here and learn more about the Company’s BioPharma solutions here. ...
This enhancement aims to offer more precise and comprehensive glycoprotein analysis, catering to the growing demands in the fields of biomedical research, disease biomarker discovery, and therapeutic development. Protein glycosylation, a major post-translational modification, significantly impacts protein folding, stability, and activity. ...
The use of mouse models enables the study of diabetes in a way that closely mirrors the disease in humans, helping to explore disease mechanisms, find biomarkers, and evaluate potential treatments. Ace Therapeutics provides diverse diabetic mouse models targeting type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), and gestational diabetes mellitus (GDM). The T1DM ...
De novo sequencing generates the first genome map for a species, while re-sequencing identifies DNA biomarkers such as single nucleotide polymorphisms (SNPs), insertions and deletions (indels), structural variations (SVs), and copy number variations (CNVs) with high accuracy. ...
FOLR1 testing is recommended for patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.1 “Expanding our offerings to include tests for specific, predictive biomarkers, like HER2, can help reveal a patient’s responsiveness to therapies that have the potential to positively impact their outcome,” said Ezra Cohen, MD, Chief Medical Officer ...
ByTempus
Tempus, a leader in artificial intelligence and precision medicine, today announces an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm physicians with technology that supports the delivery of guideline-directed biomarker testing for patients with non-small cell lung cancer (NSCLC). ...
ByTempus
This comprehensive approach is particularly valuable in the exploration of novel biomarkers and the elucidation of lncRNA-mediated regulatory networks, which often involve intricate interplays between lncRNAs and their protein-coding counterparts. ...
These include cytokines, PROTAC targets, GPCRs, labeled proteins, full-length proteins, virus-related proteins, CAR-T cell targets, biomarkers, CD antigens, and more. The company also caters to its industrial customers by offering therapeutic proteins, diagnostic proteins, and GMP proteins. ...
” Scientists of Alfa Cytology work on tailored projects by diagnosing PC and identifying its biomarkers. The ultimate aim of the company is to assist clients in developing new drugs that are more cost-effective, less toxic, and have higher efficacy and safety to meet the market’s needs. ...